Evidence map›Paper›PMID 39829402›Full record

ArticleJournal of biochemical and molecular toxicology2025

Synthesis and Characterization of Schiff Bases and Their Ag(I) Complexes Containing 2,5,6-Trisubstituted Imidazothiadiazole Derivatives: Molecular Docking and In Vitro Cytotoxic Effects Against Nonsmall Lung Cancer Cell Line.

Ahmed Hamdi Mirghani, Suray Pehlivanoglu, Hakan Alici, Hakan Tahtaci, Saban Uysal

Abstract read
In one paragraph

Article in Journal of biochemical and molecular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed Hamdi MirghaniDepartment of Chemistry, Science Faculty, Karabuk University, Karabuk, Turkey.
Suray PehlivanogluDepartment of Molecular Biology and Genetic, Science Faculty, Necmettin Erbakan University, Konya, Turkey.
Hakan AliciDepartment of Physics, Faculty of Science, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Hakan TahtaciDepartment of Chemistry, Science Faculty, Karabuk University, Karabuk, Turkey.
Saban UysalDepartment of Chemistry, Science Faculty, Karabuk University, Karabuk, Turkey.ORCID http://orcid.org/0000-0003-1061-6143

Funding

This study is funded by Karabük Üniversitesi.
6 · The paper itself

Abstract

In this study, four novels 2,5,6-trisubstituted imidazothiadiazole derivative ligands and their Ag(I) complexes were synthesized and characterized using various spectroscopic analysis techniques. First, imidazo[2,1-b][1,3,4]thiadiazole derivative (3) was obtained from the reaction of 5-amino-1,3,4-thiadiazole-2-thiol with benzyl bromide in the presence of KOH in an ethanolic medium. In the next step, the resultant compound reacted sequentially with four substituted phenacyl bromide derivatives (4a-4d) under refluxed ethanol for 24 h to obtain substituted 2-(benzylthio)-6-phenylimidazo[2,1-b][1,3,4]thiadiazole derivatives (5-8). Compounds (9-12) were obtained by attaching a carbonyl group to carbon number 5 of the imidazothiadiazole group in these compounds with the help of Vilsmeier-Haack reagent. The resultant compounds were reacted in an ethanolic medium to synthesize the novel (13-16) ligands by adding ethylenediamine in a 1:2 molar ratio. The Ag(I) complexes of the resultant ligands were synthesized by mixing silver acetate with the ligands in a dimethyl sulfoxide medium to obtain (17-20) complexes. All the synthesized compounds were analyzed using FTIR,

Indexed as

Antineoplastic AgentsCoordination ComplexesLung NeoplasmsMolecular Docking SimulationSilverThiadiazolesA549 CellsCell Line, TumorHumansImidazolesSchiff BasesAntineoplastic AgentsCoordination ComplexesImidazolesimidazothiadiazoleSchiff BasesSilverThiadiazolescytotoxic activityimidazo[2,1‐b][1,3,4]thiadiazolemolecular dockingsilver complexVilsmeier–Haack reagent

Identifiers

PMID39829402
PMCPMC11744420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.